TrialJournal of hematology & oncology2024

Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial.

Jing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.